NASDAQ Composite: development, movers and shakers at a glance

NASDAQ Composite: development, movers and shakers at a glance

According to a report by www.finanzen.net, the NASDAQ Composite closed trading almost unchanged with a gain of 0.19 percent at 14,992.97 points. Since the beginning of the year, the index has already increased by 44.34 percent, with the current annual high being 15,069.29 points.

The top stocks in the NASDAQ Composite are currently ANSYS (+18.08 percent to $357.98), Sangamo Therapeutics (+8.49 percent to $0.42), Nektar Therapeutics (+8.05 percent to $0.51), Provident Financial (+6.53 percent to $12.89) and MicroStrategy (+6.41 percent to $619.24). On the other hand, the weakest NASDAQ Composite stocks include American Bio Medica (-75.00 percent to $0.00), Arundel (-20.00 percent to $0.12), Trinity Biotech (-19.00 percent to $0.41), Escalon Medical (-9.06 percent to $0.27) and Synopsys (-6.34 percent to $524.46).

Looking at fundamentals, New York Community Bancorp stock has the lowest price-to-earnings (P/E) ratio in the index. A P/E ratio of 2.56 is expected. The highest dividend yield compared to other stocks in the index is expected to be provided by CRESUD shares at 40.50 percent.

This development of the NASDAQ Composite can have various effects. The rising values ​​of the index signal a general upward movement in the market. This can increase investor confidence and lead to more investment in the technology and growth sectors. This can also be positive for consumers, as successful technology companies can further develop their innovations and products. However, excessive speculation on further growth can also lead to the formation of a bubble, which could have negative long-term effects. It is therefore advisable to closely monitor developments in the NASDAQ Composite and react appropriately.